Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29
Brainstorm Cell Therapeutics:收到納斯達克的來信,表明截至4月29日,該公司尚未恢復遵守最低出價要求
Brainstorm Cell Therapeutics: Received Letter From Nasdaq Indicating Co Had Not Regained Compliance With Minimum Bid Price Requirement by April 29
Brainstorm Cell Therapeutics:收到納斯達克的來信,表明截至4月29日,該公司尚未恢復遵守最低出價要求
使用瀏覽器的分享功能,分享給你的好友吧